Capatina OO, Miclutia IV. Are negative symptoms in schizophrenia a distinct therapeutic target?. Med Pharm Rep [Internet]. 2018 Jan. 30 [cited 2025 Oct. 6];91(1):58-64. Available from: https://medpharmareports.com/index.php/mpr/article/view/864